NURS 2516 Clinical Medications Worksheets

(You will need to make additional copies of these forms)

Generic Name Trade Classification Dose Route Time/frequency

oxycodone/acetaminoph Name opioid analgesics 7.5/325 PO Q 4 hrs. PRN
en Percocet 1-2 tabs
Peak Onset Duration For IV meds, compatibility with IV drips and /or
60-90 min 10-15 min 3-6 hr solutions
Mechanism of action and indications Nursing Implications (what to focus on)
(Why med ordered) Contraindications/warnings/interactions
Management of moderate to severe pain Hypersensitivity
Binds to opiate receptors in the CNS
Alters the perception of and response to painful stimuli, while Common side effects
producing generalized CNS depression Confusion, sedation, constipation

Interactions with other patient drugs, OTC or herbal medicines Lab value alterations caused by medicine
(ask patient specifically) May increase plasma amylase and lipase levels
None
Be sure to teach the patient the following about
this medication
May be administered with food or milk to minimize GI
irritation, Instruct patient on how and when to ask for
pain medication, Medication may cause drowsiness or
dizziness. Advise patient to call for assistance when
ambulating or smoking. Caution patient to avoid
driving and other activities requiring alertness until
response to medication is known, Advise patient to
make position changes slowly to minimize orthostatic
hypotension, Encourage patient to turn, cough, and
breathe deeply every 2 hr to prevent atelectasis
Nursing Process- Assessment Assessment Evaluation
(Pre-administration assessment) Why would you hold or not give Check after giving
Assess type, location, and intensity of pain prior to and 1 this med? If respiratory rate is Decrease in severity of
hr (peak) after administration. When titrating opioid <10/min, assess level of sedation. pain without a significant
doses, increases of 25-50% should be administered until Physical stimulation may be alteration in level of
there is either a 50% reduction in the patient"s pain rating sufficient to prevent significant consciousness or
on a numerical or visual analog scale or the patient hypoventilation. Dose may need to respiratory status
reports satisfactory pain relief. A repeat dose can be be decreased by 25-50%. Initial Assess bowel function
safely administered at the time of the peak if previous drowsiness will diminish with routinely. Prevention of
dose is ineffective and side effects are minimal continued use constipation should be
instituted with increased
intake of fluids and bulk,
and laxatives to minimize
constipating effects.
Stimulant laxatives
should be administered
routinely if opioid use
exceeds 2-3 days, unless
contraindicated